Sat.Aug 10, 2024 - Fri.Aug 16, 2024

article thumbnail

How PBMs Impact Independent Pharmacies

Drug Topics

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed his experience as an independent pharmacy owner working under the thumb of pharmacy benefit managers.

article thumbnail

Lessons from COVID: Tuskegee impacts still erode trust in healthcare, but hope shines through

PharmaVoice

A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.

244
244
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Finerenone Significantly Reduces Cardiovascular Death, Heart Failure in the FINEARTS-HF Trial

Pharmacy Times

Non-steroidal mineralocorticoid receptor antagonist, finerenone, demonstrated improved efficacy compared with existing steroidal treatment for patients.

153
153
article thumbnail

To counter mpox, vaccine maker could ramp up by another 8 million doses next year

STAT

When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the world. The Danish company Bavarian Nordic, maker of the Jynneos smallpox vaccine, faced the sizable challenge of trying to meet demand with its supply. This week’s declaration of a second public health emergency of international concern to deal with new and concerning outbreaks of mpox in Africa has again thrust the company onto cente

Vaccines 145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Q&A: Unveiling the Current State of PBMs’ Role in Independent Pharmacy

Drug Topics

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed the current state of independent pharmacy and the role pharmacy benefit managers play within the supply chain.

article thumbnail

M&A is ready to explode, and that’s good news for pharma layoffs

PharmaVoice

Deals driven by obesity meds are fueling an M&A comeback.

233
233

More Trending

article thumbnail

STAT+: Medicare announces drug prices for historic first round of negotiations

STAT

WASHINGTON — The day drug makers dreaded has finally arrived.  Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them.  The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl

145
145
article thumbnail

Q&A: How PBMs Impact Patient Care

Drug Topics

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, shared his thoughts on how patients are treated within the drug supply chain.

article thumbnail

A biotech’s difficult journey to bring a new kind of Parkinson’s drug to patients

PharmaVoice

A series of executive turnovers at Gain Therapeutics this year precedes important early-stage Parkinson’s results that could change how the disease is treated.

189
189
article thumbnail

Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses

Pharmacy Times

RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.

Vaccines 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

As climate changes, scorching summers bring deadly heat for people with disabilities

STAT

Degree by degree, the earth’s temperature ticks up. Heat records fall as reliably as the sun sets. In July, the East Coast broiled. This week, Texas and its neighbors are feeling the burn. It’s been an absolute scorcher in the United States, the hottest summer on record. This summer might also be one of the coolest summers for the rest of your life.

145
145
article thumbnail

COVID-19’s Impact on the Leading Causes of Death in the US

Drug Topics

Experts analyzed data from the National Center for Health Statistics on the leading causes of death in the US from the last 5 years.

503
503
article thumbnail

A potential MS ‘game changer’ could bring more safety to the table — even against viruses

PharmaVoice

Immunic’s treatment has anti-inflammation, neuroprotection and antiviral effects plus a ‘benign’ safety profile that even seems to lower the risk of COVID-19 infection.

article thumbnail

JVC-001 Vaccine Demonstrates Antibody Coverage Against Measles, Mumps, and Rubella

Pharmacy Times

The seroprotection rate of antibody titers was 100% against the 3 viruses, and geometric mean titer also increased from administration to day 43.

Vaccines 144
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

WHO declares mpox outbreak a global health emergency

STAT

The World Health Organization on Wednesday declared the spread of mpox in multiple African countries a public health emergency of international concern, the second such declaration in the past two years called in response to transmission of the virus. The latest decision came on the recommendation of a panel of experts convened to advise WHO Director-General Tedros Adhanom Ghebreyesus on the issue.

145
145
article thumbnail

Prices Released for First 10 Drugs Selected in Medicare Negotiations

Drug Topics

New prices will go into effect on January 1, 2026, for individuals covered by Medicare Part D prescription drugs.

497
497
article thumbnail

The drugs hit hardest by Medicare price negotiations

PharmaVoice

The final negotiations slash drug prices between 38% and 79% for Medicare’s 2026 calendar year.

147
147
article thumbnail

Mark Cuban wants to keep shaking up healthcare. Here's Cost Plus Drug's next move

Fierce Healthcare

Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week. | Entrepreneur and investor Mark Cuban wants to "f--k up" the U.S. healthcare system to make it more affordable, the billionaire told "The Daily Show" host Jon Stewart this week.

141
141
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Opinion: Better safety studies could restore America’s confidence in vaccines

STAT

In February 2021, I received my second Covid-19 shot — the newly developed vaccine that would eventually save millions of lives worldwide — with great anticipation. It proved to be a life-changing event: Two hours later as I was driving home, the shock of a sudden loud and high-pitched whistling nearly caused me to veer off the road. It was as if an audible dog whistle began blaring right next to me.

Vaccines 145
article thumbnail

Weekend ICYMI: August 5 to August 9

Drug Topics

In case you missed it, this week we had news about opioid prescribing for patients with chronic pain, a possible link between cannabis and cancer, preparing for the upcoming flu season, and more.

453
453
article thumbnail

Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope.

PharmaVoice

The German biotech is leveraging its mRNA platforms to develop a new class of cancer treatments that are necessary to lift the company’s flagging sales.

147
147
article thumbnail

Durvalumab Receives FDA Approval for Treatment of Non-Small Cell Lung Cancer

Pharmacy Times

Durvalumab is a human monoclonal antibody that targets and binds to PD-L1 to interrupt tumor immune-evasion tactics.

article thumbnail

Antiviral used for mpox no better than placebo, NIH says

STAT

The National Institutes of Health said Thursday that an antiviral often used to treat mpox did not resolve patients’ symptoms faster than placebo in a randomized trial. The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe.

145
145
article thumbnail

Get Into Politics or Get Out of Pharmacy

Drug Topics

Our congressional representatives have plenty of interaction with PBM lobbyists. It’s time they hear from patients as well.

447
447
article thumbnail

23andMe to launch GLP-1 telehealth offering, shuts down internal drug development business

Fierce Healthcare

Consumer genetic testing company 23andMe sees an opportunity to get in on the weight loss boom. | 23andMe plans to launch a GLP-1 weight loss telehealth membership through its Lemonaid Health platform by the end of the month.

139
139
article thumbnail

Pharmacists Can Suggest B Vitamin Intake to Treat Parkinson Disease

Pharmacy Times

Individuals with Parkinson disease reported a decrease in bacterial genes for biosynthesis of riboflavin (vitamin B2) and biotin (vitamin B7).

139
139
article thumbnail

STAT+: Meet the billionaire media mogul who’s taking on the food industry

STAT

WASHINGTON — The idea for Todd Wagner’s new advocacy organization FoodFight USA, he says, came to him after visiting George Clooney in Lake Como. He’s recruited Morgan Freeman, who is “obviously” a friend. He personally lobbied Arnold Schwarzenegger and current California Gov. Gavin Newsom to support food makers’ nightmare scenario — a first-in-the-nation law banning certain food additives in the state, which was signed into law last year.

FDA 145
article thumbnail

FDA Grants Marketing Authorization to First-Ever OTC Syphilis Test

Drug Topics

First To Know Syphilis Tests are expected to be available at major national retailers and online in late 2024.

FDA 407
article thumbnail

Fair Square Medicare rolls out AI voice agents to help enroll seniors into insurance plans

Fierce Healthcare

Getting seniors enrolled into the right Medicare plan is typically an inefficient process that many older patients find confusing and frustrating, spending hours on the phone with human call center | Startup Fair Square Medicare is using advancements with generative AI to build AI-based voice agents to screen seniors for Medicare coverage and improve the customer experience.

Insurance 137
article thumbnail

Elevating Stroke Care: A Pharmacy Perspective on Telestroke Services

Pharmacy Times

In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.

139
139
article thumbnail

STAT+: Why U.S. health care cybersecurity laws are better at protecting a corpse’s privacy than patients’ lives

STAT

Two days into a cyberattack on his hospital system, Nate Couture reached the end of his cyber incident plan. “We make these incident response plans and we feel great about them,” Couture, the University of Vermont Health Network chief information security officer, told other heath care cyber professionals at a recent conference. “At the end of them, they have a box that usually says something like, ‘And then IT recovers the systems.

article thumbnail

FDA Approves Medtronic’s Disposable CGM

Drug Topics

Medtronic also announced it has entered a global partnership with Abbott in an effort to expand CGM device options for patients living with diabetes.

FDA 394
article thumbnail

CMS: Negotiated drug prices would have saved Medicare $6B last year

Fierce Healthcare

The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations. | The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations.

135
135